enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
6.70
-0.40 (-5.63%)
Jan 31, 2025, 4:00 PM EST - Market closed
enGene Holdings Employees
As of October 31, 2024, enGene Holdings had 57 total employees, including 56 full-time and 1 part-time employees. The number of employees increased by 24 or 72.73% compared to the previous year.
Employees
57
Change (1Y)
24
Growth (1Y)
72.73%
Revenue / Employee
n/a
Profits / Employee
-$967,404
Market Cap
341.54M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Oct 31, 2024 | 57 | 24 | 72.73% |
| Oct 31, 2023 | 33 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
ENGN News
- 1 day ago - enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
- 2 days ago - enGene to Present Three Posters at the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU) Highlighting the Ongoing Clinical Development of Detalimogene Voraplasmid for the Treatment of Non-Muscle Invasive Bladder Cancer (NMIBC) - Business Wire
- 6 weeks ago - enGene Reports Full Year 2024 Financial Results and Provides a Business Update - Business Wire
- 6 weeks ago - enGene Holdings: Compelling Early Data Bode Well For Their Near-Term Outlook - Seeking Alpha
- 2 months ago - enGene to Participate in Upcoming Investor Conferences - Business Wire
- 3 months ago - enGene to Participate in Guggenheim's Inaugural Healthcare Innovation Conference - Business Wire
- 3 months ago - enGene Announces $60 Million Private Placement Financing - Business Wire
- 3 months ago - enGene Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Business Wire